Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect
International Journal of Neuropsychopharmacology · 01.05.2024 · 27 (5)
DOI: 10.1093/ijnp/pyae021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 02.05.2024. Verfasst von M Gärde und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stoc…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Escitalopram, Positron-Emission Tomography, Receptor, Serotonin, 5-HT1B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Major depressive disorder (MDD) is commonly treated with selective serotonin reuptake inhibitors (SSRIs). SSRIs inhibit the serotonin transporter (5-HTT), but the downstream antidepressant mechanism of action of these drugs is poorly understood. The serotonin 1B (5-HT1B) receptor is functionally linked to 5-HTT and 5-HT1B receptor binding and 5-HT1B receptor mRNA is reduced in the raphe nuclei after SSRI administration in primates and rodents, respectively. The effect of SSRI treatment on 5-HT1B receptor binding in patients with MDD has not been examined previously. This positron emission tomography (PET) study aimed to quantify brain 5-HT1B receptor binding changes in vivo after SSRI treatment for MDD in relation to treatment effect.
Methods
Eight unmedicated patients with moderate to severe MDD underwent PET with the 5-HT1B receptor radioligand [11C]AZ10419369 before and after 3 to 4 weeks of treatment with the SSRI escitalopram 10 mg daily. Depression severity was assessed at time of PET and after 6 to 7 weeks of treatment with the Montgomery-Åsberg Depression Rating Scale.
Results
We observed a significant reduction in [11C]AZ10419369 binding in a dorsal brainstem (DBS) region containing the median and dorsal raphe nuclei after escitalopram treatment (P = .036). Change in DBS [11C]AZ10419369 binding correlated with Montgomery-Åsberg Depression Rating Scale reduction after 3-4 (r = 0.78, P = .021) and 6-7 (r = 0.94, P < .001) weeks’ treatment.
Conclusions
Our findings align with the previously reported reduction of 5-HT1B receptor binding in the raphe nuclei after SSRI administration and support future studies testing change in DBS 5-HT1B receptor binding as an SSRI treatment response marker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
- Department of Psychiatry, Columbia University, New York, USA.
- Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: M Gärde
Zitieren
APA
Gärde, M., Matheson, G. J., Varnäs, K., Svenningsson, P., Hedman-Lagerlöf, E., Lundberg, J., Farde, L., & Tiger, M. (2024). Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect. International Journal of Neuropsychopharmacology, 27(5). https://doi.org/10.1093/ijnp/pyae021
Vancouver
Gärde M, Matheson GJ, Varnäs K, Svenningsson P, Hedman-Lagerlöf E, Lundberg J, et al. Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect. International Journal of Neuropsychopharmacology. 2024;27(5). doi:10.1093/ijnp/pyae021
BibTeX
@article{Grde2024,
author = {Gärde, M and Matheson, G J and Varnäs, K and Svenningsson, P and Hedman-Lagerlöf, E and Lundberg, J and Farde, L and Tiger, M},
title = {Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect},
journal = {International Journal of Neuropsychopharmacology},
year = {2024},
volume = {27},
number = {5},
doi = {10.1093/ijnp/pyae021}
}
EUVIMED